M. Gadelha Et Al. , "Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs.," Frontiers in endocrinology , vol.10, pp.931, 2020
Gadelha, M. Et Al. 2020. Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs.. Frontiers in endocrinology , vol.10 , 931.
Gadelha, M., Bex, M., Colao, A., Garcia, E. M. P., Poiana, C., Jimenez-Sanchez, M., ... Yener, S.(2020). Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs.. Frontiers in endocrinology , vol.10, 931.
Gadelha, Monica Et Al. "Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs.," Frontiers in endocrinology , vol.10, 931, 2020
Gadelha, Monica Et Al. "Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs.." Frontiers in endocrinology , vol.10, pp.931, 2020
Gadelha, M. Et Al. (2020) . "Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs.." Frontiers in endocrinology , vol.10, p.931.
@article{article, author={Monica Gadelha Et Al. }, title={Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs.}, journal={Frontiers in endocrinology}, year=2020, pages={931} }